# Low-dose of Ticagrelor and Standard-dose Clopidogrel on Platelet Effects in Chinese Patients With Stable CAD.

> **NCT03679091** · PHASE4 · COMPLETED · sponsor: **First Affiliated Hospital of Harbin Medical University** · enrollment: 36 (actual)

## Conditions studied

- Platelet Reactivity

## Interventions

- **DRUG:** low-dose ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT03679091
- **Lead sponsor:** First Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-29
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-02-28
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03679091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03679091, "Low-dose of Ticagrelor and Standard-dose Clopidogrel on Platelet Effects in Chinese Patients With Stable CAD.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03679091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*